Latest News for: thymidine

Edit

New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference

Pharmiweb 19 Mar 2025
Thymidine kinase 2 deficiency is an ultra-rare, life-threatening, genetic mitochondrial disease characterized by progressive and severe muscle weakness (myopathy), which can impact the ability to walk, eat, and breathe independently.6,7,8,9,10.
Edit

New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference (UCB SA)

Public Technologies 19 Mar 2025
) New data on investigational therapy for thymidine kinase 2 deficiency presented at Muscular Dystrophy Association (MDA) 2025 Conference ... About thymidine kinase 2 deficiency (TK2d) ... Patients' Lived Experience of Thymidine Kinase 2 Deficiency (TK2d).
  • 1
×